Abbott Laboratories received FDA clearance for its newest continuous glucose monitor, the FreeStyle Libre 2. The product is one of many in a growing market for CGMs. Choosing the right software ...

Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...

WASHINGTON, D.C. — The Food and Drug Administration (FDA) announced that Abbott has initiated a voluntary recall for a ...

Abbott has launched the new Libre app in the U.S., making it easier than ever for users of both the FreeStyle Libre 2 and FreeStyle Libre 3 systems to track glucose readings and insights.

Abbott has entered a first-of-its-kind agreement to integrate data from FreeStyle Libre CGM systems directly into Epic electronic health record systems in the United States, allowing clinicians to vie ...